Global In-Vitro Diagnostics Technology Market

In-Vitro Diagnostics Technology Comprehensive Study by Application (Diabetes, Infectious Diseases, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids, Other Applications), Technology (Immunoassay/Immunochemistry (Enzyme-Linked Immunosorbent Assay) Players and Region - Global Market Outlook to 2032

In-Vitro Diagnostics Technology Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About In-Vitro Diagnostics Technology
In-Vitro Diagnostics (IVD) is useful for the detection of any kind of infection & diseases by taking the sample from the human body to treat diseases or its sequelae. In-vitro diagnostics products include instruments, reagents, as well as any system used for the diagnosis of diseases. The growing incidence of chronic as well as infectious diseases coupled with increasing geriatric population around the globe are the factors that drive global IVD market growth. Moreover, a growing number of public as well as private diagnostic centers & point of care testing centers are likely to impel the in-vitro diagnostics market growth over the coming years.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (United States), Abbott Laboratories (United States), Thermo Fisher Scientific (United States), Johnson & Johnson (United States), Becton, Dickinson and Company (United States), Bio-Rad Laboratories (United States), Sysmex Corporation (Japan), bioMérieux (France) and DiaSorin (Italy) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global In-Vitro Diagnostics Technology market by , Application (Diabetes, Infectious Diseases, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids and Other Applications) and Region.



On the basis of geography, the market of In-Vitro Diagnostics Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Immunoassay/Immunochemistry (Enzyme-Linked Immunosorbent Assay will boost the In-Vitro Diagnostics Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.



About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Diabetes
  • Infectious Diseases
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing/Pharmacogenomics
  • HIV/Aids
  • Other Applications
By Technology
  • Immunoassay/Immunochemistry (Enzyme-Linked Immunosorbent Assay

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Factor Analysis
    • 3.1. Porters Five Forces
    • 3.2. Supply/Value Chain
    • 3.3. PESTEL analysis
    • 3.4. Market Entropy
    • 3.5. Patent/Trademark Analysis
  • 4. Global In-Vitro Diagnostics Technology, by Application, Technology and Region (value) (2019-2024)
    • 4.1. Introduction
    • 4.2. Global In-Vitro Diagnostics Technology (Value)
      • 4.2.1. Global In-Vitro Diagnostics Technology by: Application (Value)
        • 4.2.1.1. Diabetes
        • 4.2.1.2. Infectious Diseases
        • 4.2.1.3. Oncology
        • 4.2.1.4. Cardiology
        • 4.2.1.5. Autoimmune Diseases
        • 4.2.1.6. Nephrology
        • 4.2.1.7. Drug Testing/Pharmacogenomics
        • 4.2.1.8. HIV/Aids
        • 4.2.1.9. Other Applications
      • 4.2.2. Global In-Vitro Diagnostics Technology by: Technology (Value)
        • 4.2.2.1. Immunoassay/Immunochemistry (Enzyme-Linked Immunosorbent Assay
      • 4.2.3. Global In-Vitro Diagnostics Technology Region
        • 4.2.3.1. South America
          • 4.2.3.1.1. Brazil
          • 4.2.3.1.2. Argentina
          • 4.2.3.1.3. Rest of South America
        • 4.2.3.2. Asia Pacific
          • 4.2.3.2.1. China
          • 4.2.3.2.2. Japan
          • 4.2.3.2.3. India
          • 4.2.3.2.4. South Korea
          • 4.2.3.2.5. Taiwan
          • 4.2.3.2.6. Australia
          • 4.2.3.2.7. Rest of Asia-Pacific
        • 4.2.3.3. Europe
          • 4.2.3.3.1. Germany
          • 4.2.3.3.2. France
          • 4.2.3.3.3. Italy
          • 4.2.3.3.4. United Kingdom
          • 4.2.3.3.5. Netherlands
          • 4.2.3.3.6. Rest of Europe
        • 4.2.3.4. MEA
          • 4.2.3.4.1. Middle East
          • 4.2.3.4.2. Africa
        • 4.2.3.5. North America
          • 4.2.3.5.1. United States
          • 4.2.3.5.2. Canada
          • 4.2.3.5.3. Mexico
  • 5. In-Vitro Diagnostics Technology: Manufacturers/Players Analysis
    • 5.1. Competitive Landscape
      • 5.1.1. Market Share Analysis
        • 5.1.1.1. Top 3
        • 5.1.1.2. Top 5
    • 5.2. Peer Group Analysis (2024)
    • 5.3. BCG Matrix
    • 5.4. Company Profile
      • 5.4.1. Roche Diagnostics (Switzerland)
        • 5.4.1.1. Business Overview
        • 5.4.1.2. Products/Services Offerings
        • 5.4.1.3. Financial Analysis
        • 5.4.1.4. SWOT Analysis
      • 5.4.2. Siemens Healthineers (Germany)
        • 5.4.2.1. Business Overview
        • 5.4.2.2. Products/Services Offerings
        • 5.4.2.3. Financial Analysis
        • 5.4.2.4. SWOT Analysis
      • 5.4.3. Danaher Corporation (United States)
        • 5.4.3.1. Business Overview
        • 5.4.3.2. Products/Services Offerings
        • 5.4.3.3. Financial Analysis
        • 5.4.3.4. SWOT Analysis
      • 5.4.4. Abbott Laboratories (United States)
        • 5.4.4.1. Business Overview
        • 5.4.4.2. Products/Services Offerings
        • 5.4.4.3. Financial Analysis
        • 5.4.4.4. SWOT Analysis
      • 5.4.5. Thermo Fisher Scientific (United States)
        • 5.4.5.1. Business Overview
        • 5.4.5.2. Products/Services Offerings
        • 5.4.5.3. Financial Analysis
        • 5.4.5.4. SWOT Analysis
      • 5.4.6. Johnson & Johnson (United States)
        • 5.4.6.1. Business Overview
        • 5.4.6.2. Products/Services Offerings
        • 5.4.6.3. Financial Analysis
        • 5.4.6.4. SWOT Analysis
      • 5.4.7. Becton, Dickinson and Company (United States)
        • 5.4.7.1. Business Overview
        • 5.4.7.2. Products/Services Offerings
        • 5.4.7.3. Financial Analysis
        • 5.4.7.4. SWOT Analysis
      • 5.4.8. Bio-Rad Laboratories (United States)
        • 5.4.8.1. Business Overview
        • 5.4.8.2. Products/Services Offerings
        • 5.4.8.3. Financial Analysis
        • 5.4.8.4. SWOT Analysis
      • 5.4.9. Sysmex Corporation (Japan)
        • 5.4.9.1. Business Overview
        • 5.4.9.2. Products/Services Offerings
        • 5.4.9.3. Financial Analysis
        • 5.4.9.4. SWOT Analysis
      • 5.4.10. BioMérieux (France)
        • 5.4.10.1. Business Overview
        • 5.4.10.2. Products/Services Offerings
        • 5.4.10.3. Financial Analysis
        • 5.4.10.4. SWOT Analysis
      • 5.4.11. DiaSorin (Italy)
        • 5.4.11.1. Business Overview
        • 5.4.11.2. Products/Services Offerings
        • 5.4.11.3. Financial Analysis
        • 5.4.11.4. SWOT Analysis
  • 6. Global In-Vitro Diagnostics Technology Sale, by Application, Technology and Region (value) (2027-2032)
    • 6.1. Introduction
    • 6.2. Global In-Vitro Diagnostics Technology (Value)
      • 6.2.1. Global In-Vitro Diagnostics Technology by: Application (Value)
        • 6.2.1.1. Diabetes
        • 6.2.1.2. Infectious Diseases
        • 6.2.1.3. Oncology
        • 6.2.1.4. Cardiology
        • 6.2.1.5. Autoimmune Diseases
        • 6.2.1.6. Nephrology
        • 6.2.1.7. Drug Testing/Pharmacogenomics
        • 6.2.1.8. HIV/Aids
        • 6.2.1.9. Other Applications
      • 6.2.2. Global In-Vitro Diagnostics Technology by: Technology (Value)
        • 6.2.2.1. Immunoassay/Immunochemistry (Enzyme-Linked Immunosorbent Assay
      • 6.2.3. Global In-Vitro Diagnostics Technology Region
        • 6.2.3.1. South America
          • 6.2.3.1.1. Brazil
          • 6.2.3.1.2. Argentina
          • 6.2.3.1.3. Rest of South America
        • 6.2.3.2. Asia Pacific
          • 6.2.3.2.1. China
          • 6.2.3.2.2. Japan
          • 6.2.3.2.3. India
          • 6.2.3.2.4. South Korea
          • 6.2.3.2.5. Taiwan
          • 6.2.3.2.6. Australia
          • 6.2.3.2.7. Rest of Asia-Pacific
        • 6.2.3.3. Europe
          • 6.2.3.3.1. Germany
          • 6.2.3.3.2. France
          • 6.2.3.3.3. Italy
          • 6.2.3.3.4. United Kingdom
          • 6.2.3.3.5. Netherlands
          • 6.2.3.3.6. Rest of Europe
        • 6.2.3.4. MEA
          • 6.2.3.4.1. Middle East
          • 6.2.3.4.2. Africa
        • 6.2.3.5. North America
          • 6.2.3.5.1. United States
          • 6.2.3.5.2. Canada
          • 6.2.3.5.3. Mexico
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. In-Vitro Diagnostics Technology: by Application(USD Million)
  • Table 2. In-Vitro Diagnostics Technology Diabetes , by Region USD Million (2019-2024)
  • Table 3. In-Vitro Diagnostics Technology Infectious Diseases , by Region USD Million (2019-2024)
  • Table 4. In-Vitro Diagnostics Technology Oncology , by Region USD Million (2019-2024)
  • Table 5. In-Vitro Diagnostics Technology Cardiology , by Region USD Million (2019-2024)
  • Table 6. In-Vitro Diagnostics Technology Autoimmune Diseases , by Region USD Million (2019-2024)
  • Table 7. In-Vitro Diagnostics Technology Nephrology , by Region USD Million (2019-2024)
  • Table 8. In-Vitro Diagnostics Technology Drug Testing/Pharmacogenomics , by Region USD Million (2019-2024)
  • Table 9. In-Vitro Diagnostics Technology HIV/Aids , by Region USD Million (2019-2024)
  • Table 10. In-Vitro Diagnostics Technology Other Applications , by Region USD Million (2019-2024)
  • Table 11. In-Vitro Diagnostics Technology: by Technology(USD Million)
  • Table 12. In-Vitro Diagnostics Technology Immunoassay/Immunochemistry (Enzyme-Linked Immunosorbent Assay , by Region USD Million (2019-2024)
  • Table 13. South America In-Vitro Diagnostics Technology, by Country USD Million (2019-2024)
  • Table 14. South America In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 15. South America In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 16. Brazil In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 17. Brazil In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 18. Argentina In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 19. Argentina In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 20. Rest of South America In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 21. Rest of South America In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 22. Asia Pacific In-Vitro Diagnostics Technology, by Country USD Million (2019-2024)
  • Table 23. Asia Pacific In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 24. Asia Pacific In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 25. China In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 26. China In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 27. Japan In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 28. Japan In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 29. India In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 30. India In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 31. South Korea In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 32. South Korea In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 33. Taiwan In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 34. Taiwan In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 35. Australia In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 36. Australia In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 37. Rest of Asia-Pacific In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 38. Rest of Asia-Pacific In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 39. Europe In-Vitro Diagnostics Technology, by Country USD Million (2019-2024)
  • Table 40. Europe In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 41. Europe In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 42. Germany In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 43. Germany In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 44. France In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 45. France In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 46. Italy In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 47. Italy In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 48. United Kingdom In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 49. United Kingdom In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 50. Netherlands In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 51. Netherlands In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 52. Rest of Europe In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 53. Rest of Europe In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 54. MEA In-Vitro Diagnostics Technology, by Country USD Million (2019-2024)
  • Table 55. MEA In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 56. MEA In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 57. Middle East In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 58. Middle East In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 59. Africa In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 60. Africa In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 61. North America In-Vitro Diagnostics Technology, by Country USD Million (2019-2024)
  • Table 62. North America In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 63. North America In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 64. United States In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 65. United States In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 66. Canada In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 67. Canada In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 68. Mexico In-Vitro Diagnostics Technology, by Application USD Million (2019-2024)
  • Table 69. Mexico In-Vitro Diagnostics Technology, by Technology USD Million (2019-2024)
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. In-Vitro Diagnostics Technology: by Application(USD Million)
  • Table 82. In-Vitro Diagnostics Technology Diabetes , by Region USD Million (2027-2032)
  • Table 83. In-Vitro Diagnostics Technology Infectious Diseases , by Region USD Million (2027-2032)
  • Table 84. In-Vitro Diagnostics Technology Oncology , by Region USD Million (2027-2032)
  • Table 85. In-Vitro Diagnostics Technology Cardiology , by Region USD Million (2027-2032)
  • Table 86. In-Vitro Diagnostics Technology Autoimmune Diseases , by Region USD Million (2027-2032)
  • Table 87. In-Vitro Diagnostics Technology Nephrology , by Region USD Million (2027-2032)
  • Table 88. In-Vitro Diagnostics Technology Drug Testing/Pharmacogenomics , by Region USD Million (2027-2032)
  • Table 89. In-Vitro Diagnostics Technology HIV/Aids , by Region USD Million (2027-2032)
  • Table 90. In-Vitro Diagnostics Technology Other Applications , by Region USD Million (2027-2032)
  • Table 91. In-Vitro Diagnostics Technology: by Technology(USD Million)
  • Table 92. In-Vitro Diagnostics Technology Immunoassay/Immunochemistry (Enzyme-Linked Immunosorbent Assay , by Region USD Million (2027-2032)
  • Table 93. South America In-Vitro Diagnostics Technology, by Country USD Million (2027-2032)
  • Table 94. South America In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 95. South America In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 96. Brazil In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 97. Brazil In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 98. Argentina In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 99. Argentina In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 100. Rest of South America In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 101. Rest of South America In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 102. Asia Pacific In-Vitro Diagnostics Technology, by Country USD Million (2027-2032)
  • Table 103. Asia Pacific In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 104. Asia Pacific In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 105. China In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 106. China In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 107. Japan In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 108. Japan In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 109. India In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 110. India In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 111. South Korea In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 112. South Korea In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 113. Taiwan In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 114. Taiwan In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 115. Australia In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 116. Australia In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 117. Rest of Asia-Pacific In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 118. Rest of Asia-Pacific In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 119. Europe In-Vitro Diagnostics Technology, by Country USD Million (2027-2032)
  • Table 120. Europe In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 121. Europe In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 122. Germany In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 123. Germany In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 124. France In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 125. France In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 126. Italy In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 127. Italy In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 128. United Kingdom In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 129. United Kingdom In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 130. Netherlands In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 131. Netherlands In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 132. Rest of Europe In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 133. Rest of Europe In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 134. MEA In-Vitro Diagnostics Technology, by Country USD Million (2027-2032)
  • Table 135. MEA In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 136. MEA In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 137. Middle East In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 138. Middle East In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 139. Africa In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 140. Africa In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 141. North America In-Vitro Diagnostics Technology, by Country USD Million (2027-2032)
  • Table 142. North America In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 143. North America In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 144. United States In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 145. United States In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 146. Canada In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 147. Canada In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 148. Mexico In-Vitro Diagnostics Technology, by Application USD Million (2027-2032)
  • Table 149. Mexico In-Vitro Diagnostics Technology, by Technology USD Million (2027-2032)
  • Table 150. Research Programs/Design for This Report
  • Table 151. Key Data Information from Secondary Sources
  • Table 152. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global In-Vitro Diagnostics Technology: by Application USD Million (2019-2024)
  • Figure 5. Global In-Vitro Diagnostics Technology: by Technology USD Million (2019-2024)
  • Figure 6. South America In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 7. Asia Pacific In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 8. Europe In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 9. MEA In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 10. North America In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 11. Global In-Vitro Diagnostics Technology share by Players 2024 (%)
  • Figure 12. Global In-Vitro Diagnostics Technology share by Players (Top 3) 2024(%)
  • Figure 13. Global In-Vitro Diagnostics Technology share by Players (Top 5) 2024(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 16. Roche Diagnostics (Switzerland) Revenue: by Geography 2024
  • Figure 17. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Siemens Healthineers (Germany) Revenue: by Geography 2024
  • Figure 19. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Danaher Corporation (United States) Revenue: by Geography 2024
  • Figure 21. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 22. Abbott Laboratories (United States) Revenue: by Geography 2024
  • Figure 23. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 24. Thermo Fisher Scientific (United States) Revenue: by Geography 2024
  • Figure 25. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 26. Johnson & Johnson (United States) Revenue: by Geography 2024
  • Figure 27. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton, Dickinson and Company (United States) Revenue: by Geography 2024
  • Figure 29. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Bio-Rad Laboratories (United States) Revenue: by Geography 2024
  • Figure 31. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Sysmex Corporation (Japan) Revenue: by Geography 2024
  • Figure 33. BioMérieux (France) Revenue, Net Income and Gross profit
  • Figure 34. BioMérieux (France) Revenue: by Geography 2024
  • Figure 35. DiaSorin (Italy) Revenue, Net Income and Gross profit
  • Figure 36. DiaSorin (Italy) Revenue: by Geography 2024
  • Figure 37. Global In-Vitro Diagnostics Technology: by Application USD Million (2027-2032)
  • Figure 38. Global In-Vitro Diagnostics Technology: by Technology USD Million (2027-2032)
  • Figure 39. South America In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 40. Asia Pacific In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 41. Europe In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 42. MEA In-Vitro Diagnostics Technology Share (%), by Country
  • Figure 43. North America In-Vitro Diagnostics Technology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (Germany)
  • Danaher Corporation (United States)
  • Abbott Laboratories (United States)
  • Thermo Fisher Scientific (United States)
  • Johnson & Johnson (United States)
  • Becton, Dickinson and Company (United States)
  • Bio-Rad Laboratories (United States)
  • Sysmex Corporation (Japan)
  • bioMérieux (France)
  • DiaSorin (Italy)
Select User Access Type

Key Highlights of Report


Mar 2025 235 Pages 61 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global In-Vitro Diagnostics Technology Market Quantitative research analysis
Global In-Vitro Diagnostics Technology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (United States), Abbott Laboratories (United States), Thermo Fisher Scientific (United States), Johnson & Johnson (United States), Becton, Dickinson and Company (United States), Bio-Rad Laboratories (United States), Sysmex Corporation (Japan), bioMérieux (France) and DiaSorin (Italy) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for In-Vitro Diagnostics Technology Market during projected period 2024-2032.
The In-Vitro Diagnostics Technology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global In-Vitro Diagnostics Technology Market Report?

Have a Query? Click Here

Other Related Reports

Screenless Display Technology Future-proof Comprehensive Study by Application (Holographic Projection, Head-mounted Display, Head-up Display, Others), Type (Visual Image, Retinal Display, Synaptic I...
$ 3800